218 related articles for article (PubMed ID: 27663182)
1. Cholesterol 24-hydroxylase: Brain cholesterol metabolism and beyond.
Moutinho M; Nunes MJ; Rodrigues E
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1911-1920. PubMed ID: 27663182
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.
Petrov AM; Pikuleva IA
Neurotherapeutics; 2019 Jul; 16(3):635-648. PubMed ID: 31001737
[TBL] [Abstract][Full Text] [Related]
3. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.
Kacher R; Lamazière A; Heck N; Kappes V; Mounier C; Despres G; Dembitskaya Y; Perrin E; Christaller W; Sasidharan Nair S; Messent V; Cartier N; Vanhoutte P; Venance L; Saudou F; Néri C; Caboche J; Betuing S
Brain; 2019 Aug; 142(8):2432-2450. PubMed ID: 31286142
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1).
Mast N; Lin JB; Anderson KW; Bjorkhem I; Pikuleva IA
PLoS One; 2017; 12(10):e0187168. PubMed ID: 29073233
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol redistribution triggered by CYP46A1 gene therapy improves major hallmarks of Niemann-Pick type C disease but is not sufficient to halt neurodegeneration.
Nunes MJ; Carvalho AN; Reis J; Costa D; Moutinho M; Mateus J; Mendes de Almeida R; Brito S; Risso D; Nunes S; Castro-Caldas M; Gama MJ; Rodrigues CMP; Xapelli S; Diógenes MJ; Cartier N; Chali F; Piguet F; Rodrigues E
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):166993. PubMed ID: 38142760
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma.
Han M; Wang S; Yang N; Wang X; Zhao W; Saed HS; Daubon T; Huang B; Chen A; Li G; Miletic H; Thorsen F; Bjerkvig R; Li X; Wang J
EMBO Mol Med; 2020 Jan; 12(1):e10924. PubMed ID: 31777202
[TBL] [Abstract][Full Text] [Related]
7. The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms.
Alavi MS; Karimi G; Ghanimi HA; Roohbakhsh A
Eur J Pharmacol; 2023 Jun; 949():175726. PubMed ID: 37062503
[TBL] [Abstract][Full Text] [Related]
8. CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content.
Boussicault L; Kacher R; Lamazière A; Vanhoutte P; Caboche J; Betuing S; Potier MC
Biochimie; 2018 Oct; 153():70-79. PubMed ID: 30107216
[TBL] [Abstract][Full Text] [Related]
9.
Mast N; Anderson KW; Johnson KM; Phan TTN; Guengerich FP; Pikuleva IA
J Biol Chem; 2017 Aug; 292(31):12934-12946. PubMed ID: 28642370
[TBL] [Abstract][Full Text] [Related]
10. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.
Djelti F; Braudeau J; Hudry E; Dhenain M; Varin J; Bièche I; Marquer C; Chali F; Ayciriex S; Auzeil N; Alves S; Langui D; Potier MC; Laprevote O; Vidaud M; Duyckaerts C; Miles R; Aubourg P; Cartier N
Brain; 2015 Aug; 138(Pt 8):2383-98. PubMed ID: 26141492
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 27A1 Deficiency and Regional Differences in Brain Sterol Metabolism Cause Preferential Cholestanol Accumulation in the Cerebellum.
Mast N; Anderson KW; Lin JB; Li Y; Turko IV; Tatsuoka C; Bjorkhem I; Pikuleva IA
J Biol Chem; 2017 Mar; 292(12):4913-4924. PubMed ID: 28190002
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of oral turinabol by the human brain cholesterol 24-hydroxylase CYP46A1.
Putkaradze N; Hartz P; Hutter MC; Zapp J; Thevis M; Bernhardt R
J Steroid Biochem Mol Biol; 2021 Sep; 212():105927. PubMed ID: 34089835
[TBL] [Abstract][Full Text] [Related]
13. Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity.
Anderson KW; Mast N; Hudgens JW; Lin JB; Turko IV; Pikuleva IA
J Biol Chem; 2016 May; 291(22):11876-86. PubMed ID: 27056331
[TBL] [Abstract][Full Text] [Related]
14. The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo.
Shafaati M; Mast N; Beck O; Nayef R; Heo GY; Björkhem-Bergman L; Lütjohann D; Björkhem I; Pikuleva IA
J Lipid Res; 2010 Feb; 51(2):318-23. PubMed ID: 19474457
[TBL] [Abstract][Full Text] [Related]
15. In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina.
Fourgeux C; Martine L; Acar N; Bron AM; Creuzot-Garcher CP; Bretillon L
Biochem Biophys Res Commun; 2014 Apr; 446(3):775-81. PubMed ID: 24491555
[TBL] [Abstract][Full Text] [Related]
16. Oxysterols as biomarkers in neurodegenerative diseases.
Leoni V; Caccia C
Chem Phys Lipids; 2011 Sep; 164(6):515-24. PubMed ID: 21515244
[TBL] [Abstract][Full Text] [Related]
17. Marked change in the balance between CYP27A1 and CYP46A1 mediated elimination of cholesterol during differentiation of human neuronal cells.
Milagre I; Olin M; Nunes MJ; Moutinho M; Lövgren-Sandblom A; Gama MJ; Björkhem I; Rodrigues E
Neurochem Int; 2012 Jan; 60(2):192-8. PubMed ID: 22185844
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds.
Mast N; Verwilst P; Wilkey CJ; Guengerich FP; Pikuleva IA
J Med Chem; 2020 Jun; 63(12):6477-6488. PubMed ID: 31617715
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of cholesterol 24-hydroxylase following hypoxia-ischemia in neonatal mouse brain.
Lu F; Zhu J; Guo S; Wong BJ; Chehab FF; Ferriero DM; Jiang X
Pediatr Res; 2018 Jun; 83(6):1218-1227. PubMed ID: 29718007
[TBL] [Abstract][Full Text] [Related]
20. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination.
Milagre I; Nunes MJ; Moutinho M; Rivera I; Fuso A; Scarpa S; Gama MJ; Rodrigues E
J Alzheimers Dis; 2010; 22(4):1209-21. PubMed ID: 20930312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
